Skip to main content

Find Clinical Trials

Home
Conditions
NASH - Nonalcoholic Steatohepatitis

Clinical trial condition

NASH - Nonalcoholic Steatohepatitis

Explore clinical trials studying NASH - Nonalcoholic Steatohepatitis. Study availability and eligibility vary by location and protocol.

78 public trials 8 recruiting studies

Refine in advanced search Browse all conditions

NASH - Nonalcoholic Steatohepatitis trial results

Enrolling by Invitation

Disease Prevention in Clinical Practice Base on Patient Specific Physiology

NCT03308773

Conditions: Arrhythmias, Cardiac, Arterial Occlusive Diseases, Arteriosclerosis, +32 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy and Safety of SNP-610 for the Treatment of Patients With Non-alcoholic Steatohepatitis

NCT03468556

Conditions: Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Integrated Phenotyping of the Gut-plAtelet-Liver AXIS in the Progression of Chronic Liver Disease (iGAL-AXIS)

NCT06623084

Conditions: Cirrhosis, Control Condition, Digestive System Diseases, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

THE FRENCH NATIONAL NAFLD COHORT (FRench pAtients With MEtabolic Steatosis)

NCT04925362

Conditions: Cirrhosis, Digestive System Diseases, Fatty Liver, +8 more
Locations: Not specified

View Trial Details

Completed

A Study of Efruxifermin in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) (Symmetry)

NCT05039450

Conditions: Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations: Akero Clinical Study Site Chandler, Arizona, United States

Akero Clinical Study Site Glendale, Arizona, United States

Akero Clinical Study Site Tucson, Arizona, United States

Akero Clinical Study Site Tucson, Arizona, United States

View all 49 locations

View Trial Details

Completed

Phase 2a Study of HPG1860 in Subjects With NASH

NCT05338034

Conditions: Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations: South Texas Research Institute (STRI) Texas City, Texas, United States

View Trial Details

Completed

Feasibility, Safety and Acceptability of a Mobile Health Delivered Exercise Training Program in Patients With Nonalcoholic Steatohepatitis

NCT06195943

Conditions: Behavior, Digestive System Diseases, Exercise, +7 more
Locations: Penn State Hershey Medical Center Hershey, Pennsylvania, United States

View Trial Details

Completed

Quantifying Body Composition and Liver Disease in Children Using Free-Breathing MRI and MRE

NCT04591106

Conditions: Digestive System Diseases, Fatty Liver, Fibrosis, +6 more
Locations: UCLA Medical Center Los Angeles, California, United States

View Trial Details

Completed

The Impact of Ibutamoren on Nonalcoholic Fatty Liver Disease

NCT05364684

Conditions: Digestive System Diseases, Fatty Liver, Liver Diseases, +4 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Study Evaluating the Safety, Efficacy and Tolerability of BIO89-100 in Subjects With Biopsy-confirmed Nonalcoholic Steatohepatitis (NASH)

NCT04929483

Conditions: Digestive System Diseases, Fatty Liver, Liver Diseases, +4 more
Locations: 89bio Clinical Study Site Birmingham, Alabama, United States

89bio Clinical Study Site Birmingham, Alabama, United States

89bio Clinical Study Site Dothan, Alabama, United States

89bio Clinical Study Site Guntersville, Alabama, United States

View all 89 locations

View Trial Details